Mendus has entered into a collaboration with the Australasian Leukaemia & Lymphoma Group (ALLG) to i...
Redeye is pleased to note that Smart Eye has received two new contracts for a total of SEK 300m and ...
MindArk redovisade en ökad nettoomsättning och minskad EBIT i det tredje kvartalet.
Redeye is encouraged by the preliminary Q4 (Oct-Nov) sales, and we positively review the sales estim...
Goodbye Kansas Group genomför 6 - 20 december år 2023 en företrädesemission.
Redeye takes a positive stance towards Hanza’s direct share issue.
Redeye states that Systemair posted solid Q2 numbers, very much in-line with our expectations.
Partner prioriterar Bolagets partner IGM Biosciences meddelade igår att de fokuserar sina resurser m...
Redeye is optimistic about the success of the safety cohort review.
Mindark PE (”Mindark” eller ”Bolaget”) uppvisade under kv3 2023 en nettoomsättning på 22,9 MSEK – i ...
Redeye comments on FlexQube’s breakthrough order for its first autonomous robot (AMR), the Navigator...
NOSIUM levererade en solid Q3-rapport där det är positivt att Bolaget överträffade sin målsättning v...
Nya finansiella mål presenterade med fokus på tillväxt.
Yesterday, NeoDynamics released two press releases.
Huddlestock Fintech AS (”Huddlestock” or the ”Company”) has demonstrated a high business pace during...
Mangold uppdaterar cybersäkerhetsbolaget Cyber Security 1 (”CYBER1”) efter det tredje kvartalet 2023...
Positive sales update for Q4 Oct-Nov sales of 25.2m (ABGSCe Q4 SEK 24) Implied upside of 13% to our ...
Redeye comments on the first phase I clinical data on BI-1607 communicated yesterday by BioInvent.
Redeye initiates coverage of Iconovo, a Swedish medtech company specialising in developing inhalatio...
